1-229431527-G-A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PS4_ModeratePP4_StrongPP2PP3PP1PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The c.1106C>T (p.Pro369Leu) variant in ACTA1 is a missense variant predicted to cause substitution of proline by leucine at amino acid 369. This variant is absent from gnomAD v4.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.922, which is above the threshold of 0.7, evidence that correlates with impact to ACTA1 function (PP3). ACTA1, in which the variant was identified, is defined by the ClinGen Congenital Myopathies VCEP as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (PP2). This variant has been reported in 4 probands with nemaline myopathy, 1 with nemaline rods (PS4_Moderate; PMIDs: 19562689, 26172852; ClinVar SCVs: SCV000589626.2, SCV002287790.1; Internal lab contributors: GeneDx, Invitae). At least one patient with this variant displayed nemaline rods and type 1 fiber predominance, which is highly specific for alpha-actinopathy (PP4_Moderate, PMID:26172852). The variant has been reported to segregate with autosomal dominant nemaline myopathy in 3 affected family members from 1 family (PP1; ClinVar SCV: SCV000589626.2, Internal lab contributors: GeneDx). In summary, this variant meets the criteria to be classified as pathogenic for autosomal dominant alpha-actinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: PP4_Strong, PS4_Moderate, PM2_Supporting, PP1, PP2, PP3. (Congenital Myopathies VCEP specifications version 2; 08/27/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA345144203/MONDO:0100084/147
Frequency
Consequence
NM_001100.4 missense
Scores
Clinical Significance
Conservation
Publications
- alpha-actinopathyInheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
- congenital myopathy 2a, typical, autosomal dominantInheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital myopathy with excess of thin filamentsInheritance: SD Classification: DEFINITIVE Submitted by: Illumina
- congenital myopathy 2c, severe infantile, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fiber-type disproportion myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- progressive scapulohumeroperoneal distal myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- rigid spine syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- zebra body myopathyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTA1 | ENST00000366684.7 | c.1106C>T | p.Pro369Leu | missense_variant | Exon 7 of 7 | 1 | NM_001100.4 | ENSP00000355645.3 | ||
ACTA1 | ENST00000366683.4 | c.1028C>T | p.Pro343Leu | missense_variant | Exon 7 of 7 | 5 | ENSP00000355644.4 | |||
ACTA1 | ENST00000684723.1 | c.971C>T | p.Pro324Leu | missense_variant | Exon 6 of 6 | ENSP00000508084.1 | ||||
ENSG00000290037 | ENST00000702606.2 | n.162G>A | non_coding_transcript_exon_variant | Exon 1 of 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Actin accumulation myopathy Pathogenic:1
This sequence change replaces proline with leucine at codon 369 of the ACTA1 protein (p.Pro369Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individuals with autosomal dominant ACTA1-related conditions (PMID: 19562689, 26172852). ClinVar contains an entry for this variant (Variation ID: 431989). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACTA1 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Alpha-actinopathy Pathogenic:1
The c.1106C>T (p.Pro369Leu) variant in ACTA1 is a missense variant predicted to cause substitution of proline by leucine at amino acid 369. This variant is absent from gnomAD v4.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.922, which is above the threshold of 0.7, evidence that correlates with impact to ACTA1 function (PP3). ACTA1, in which the variant was identified, is defined by the ClinGen Congenital Myopathies VCEP as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (PP2). This variant has been reported in 4 probands with nemaline myopathy, 1 with nemaline rods (PS4_Moderate; PMIDs: 19562689, 26172852; ClinVar SCVs: SCV000589626.2, SCV002287790.1; Internal lab contributors: GeneDx, Invitae). At least one patient with this variant displayed nemaline rods and type 1 fiber predominance, which is highly specific for alpha-actinopathy (PP4_Moderate, PMID: 26172852). The variant has been reported to segregate with autosomal dominant nemaline myopathy in 3 affected family members from 1 family (PP1; ClinVar SCV: SCV000589626.2, Internal lab contributors: GeneDx). In summary, this variant meets the criteria to be classified as pathogenic for autosomal dominant alpha-actinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: PP4_Strong, PS4_Moderate, PM2_Supporting, PP1, PP2, PP3. (Congenital Myopathies VCEP specifications version 2; 08/27/2024) -
not provided Pathogenic:1
The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26172852, 19562689) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at